about
Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?Avidity of antibodies against HSV-2 and risk to neonatal transmission among Mexican pregnant women.Risk factors for anal HPV-16/18 infection in Mexican HIV-infected men who have sex with men.Dissecting the role of integrin subunits alpha 2 and beta 3 in rotavirus cell entry by RNA silencing.Heterogeneity of Herpes Simplex Virus Type 2 Seroprevalence From a National Probability Survey In Mexico, 2012.Evaluation of the Antimicrobial Activity of a Super Oxidized Solution in Clinical Isolates.HPV infection, risk factors and viral load among Mexican male college students.Real time PCR to evaluate HSV-2 shedding from anal and genital samples among men who have sex with men, living with HIV.College women, HPV genotyping and sexual behavior before HPV vaccination: Results from samples stored for a long time.Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000-2014).[Detection of antibodies against HIV from dry blood samples on filter paper].Serum leptin is associated with metabolic syndrome in obese Mexican subjects.The hidden burden of Chikungunya in central Mexico: results of a small-scale serosurvey.Serosurvey of antibodies against Toxoplasma gondii and Neospora caninum in white-tailed deer from Northern MexicoChanges in cardiovascular risk and clinical outcomes in a HIV/AIDS cohort study over a 1-year period at a specialized clinic in MexicoHepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) resultsPerformance of ELISA and Western blot to detect antibodies against HSV-2 using dried blood spotsIgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancerQuantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancerAnalysis of self-reported adverse reactions to efavirenz and drug interactions in a population with HIV in MexicoPrevalence of active infection by herpes simplex virus type 2 in patients with high-risk human papillomavirus infection: A cross-sectional study
P50
Q34190023-CA8CA07B-C259-4137-8F36-58E04A10A614Q37108853-868D55D0-3E7E-412B-AC25-20185E1DB899Q39124088-0FB4BC14-DB9E-4FB4-B088-A79ECE49F4C3Q39820195-39BEA013-95BA-4ABC-ACBE-0B94D3BCC2C1Q40056220-661DB7D2-8AAF-4E70-BF5E-9232F620D9F6Q41155112-59809EA3-55B8-4CA4-B873-E8BE1EF1B040Q42268020-80CE6838-6E60-4E14-A5B9-8DBD1F0C29C2Q47566286-7A090850-A770-4AE6-8162-62834D8F51BAQ47615740-09093C06-5D70-456E-B7E0-C2693D07EA64Q47984547-3414CBAE-F41D-420F-903F-602740E607C0Q49930646-FC6170CF-D3CD-462E-942B-1EF5E9529523Q50706914-64950C17-E1C7-4B5A-9302-3943440176AEQ54229091-3E88B3D8-B105-422A-93F3-F3D111D9C28DQ56768631-AE8F9379-FC3B-4B4F-834C-B98C815F828CQ57070083-D0229B11-B305-4AFD-8DC4-C062D0FB018BQ58088128-AF65ACE6-903F-4A24-9A71-C2AF5322271EQ58593306-25B79053-83BF-4231-B4E3-3AC765A67566Q85839261-69129238-C00C-43F2-8E98-4B9A7AA25817Q90504385-A77108C1-92FE-41D0-8D52-2C06790DA80BQ92481421-0B142A14-89BD-4BAD-B773-FA6E6202EF92Q92567431-F71B7D5B-01D2-47F6-815D-84323DCF6041
P50
description
investigador
@es
researcher
@en
name
Miguel A Sánchez-Alemán
@en
type
label
Miguel A Sánchez-Alemán
@en
prefLabel
Miguel A Sánchez-Alemán
@en
P31
P496
0000-0003-2383-7930